| AB001. OS01. 01. Post op radiation may be detrimental in thymoma but not in thymic carcinoma tumors W Wang, Y Zang, H Zhang, J Smith, S Badve, K Kesler, RP Nelson, ... Mediastinum 1 (9), 2017 | 355 | 2017 |
| Adaptive designs for identifying optimal biological dose for molecularly targeted agents Y Zang, JJ Lee, Y Yuan Clinical Trials 11 (3), 319-327, 2014 | 92 | 2014 |
| A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data N Alghamdi, W Chang, P Dang, X Lu, C Wan, S Gampala, Z Huang, ... Genome research 31 (10), 1867-1884, 2021 | 67 | 2021 |
| Simple algorithms to calculate asymptotic null distributions of robust tests in case-control genetic association studies in R Y Zang, WK Fung, G Zheng Journal of Statistical software 33, 1-24, 2010 | 62 | 2010 |
| IDO immune status after chemoradiation may predict survival in lung cancer patients W Wang, L Huang, JY Jin, S Jolly, Y Zang, H Wu, L Yan, W Pi, L Li, ... Cancer research 78 (3), 809-816, 2018 | 60 | 2018 |
| LTMG: a novel statistical modeling of transcriptional expression states in single-cell RNA-Seq data C Wan, W Chang, Y Zhang, F Shah, X Lu, Y Zang, A Zhang, S Cao, ... Nucleic acids research 47 (18), e111-e111, 2019 | 52 | 2019 |
| Adaptive clinical trial designs in oncology Y Zang, JJ Lee Chinese clinical oncology 3 (4), 2014 | 44 | 2014 |
| Histology, tumor volume, and radiation dose predict outcomes in NSCLC patients after stereotactic ablative radiotherapy K Shiue, A Cerra-Franco, R Shapiro, N Estabrook, EM Mannina, CR Deig, ... Journal of Thoracic Oncology 13 (10), 1549-1559, 2018 | 39 | 2018 |
| A robust two‐stage design identifying the optimal biological dose for phase I/II clinical trials Y Zang, JJ Lee Statistics in medicine 36 (1), 27-42, 2017 | 29 | 2017 |
| An in vivo screen identifies PYGO2 as a driver for metastatic prostate cancer X Lu, X Pan, CJ Wu, D Zhao, S Feng, Y Zang, R Lee, S Khadka, SB Amin, ... Cancer research 78 (14), 3823-3833, 2018 | 25 | 2018 |
| Substantial hepatic necrosis is prognostic in fulminant liver failure P Ndekwe, MS Ghabril, Y Zang, SA Mann, OW Cummings, J Lin World Journal of Gastroenterology 23 (23), 4303, 2017 | 22 | 2017 |
| Robust genomic control and robust delta centralization tests for case-control association studies Y Zang, H Zhang, Y Yang, G Zheng Human heredity 63 (3-4), 187-195, 2007 | 20 | 2007 |
| A Bayesian adaptive phase I/II clinical trial design with late-onset competing risk outcomes Y Zhang, S Cao, C Zhang, IH Jin, Y Zang Biometrics 77 (3), 796-808, 2021 | 18 | 2021 |
| Drug–gene and drug–drug interactions associated with tramadol and codeine therapy in the INGENIOUS trial CR Fulton, Y Zang, Z Desta, MB Rosenman, AM Holmes, BS Decker, ... Pharmacogenomics 20 (06), 397-408, 2019 | 18 | 2019 |
| A novel perioperative multidose methadone-based multimodal analgesic strategy in children achieved safe and low analgesic blood methadone levels enabling opioid-sparing … S Sadhasivam, BW Aruldhas, S Packiasabapathy, BR Overholser, ... Anesthesia & Analgesia 133 (2), 327-337, 2021 | 15 | 2021 |
| Pilot study of fetal brain development and morphometry in prenatal opioid exposure and smoking on fetal MRI R Radhakrishnan, BP Brown, DM Haas, Y Zang, C Sparks, S Sadhasivam Journal of Neuroradiology 49 (1), 53-58, 2022 | 12 | 2022 |
| Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition A Le, H Mohammadi, T Mohammed, H Burney, Y Zang, D Frye, K Shiue, ... Journal of Neuro-Oncology 158 (3), 481-488, 2022 | 11 | 2022 |
| Supervised clustering of high-dimensional data using regularized mixture modeling W Chang, C Wan, Y Zang, C Zhang, S Cao Briefings in bioinformatics 22 (4), bbaa291, 2021 | 11 | 2021 |
| Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification Y Zang, J Jack Lee, Y Yuan Journal of the Royal Statistical Society Series C: Applied Statistics 65 (4 …, 2016 | 10 | 2016 |
| Robust Mantel‐Haenszel test under genetic model uncertainty allowing for covariates in case‐control association studies Y Zang, WK Fung Genetic Epidemiology 35 (7), 695-705, 2011 | 10 | 2011 |
